how do i purchase via a Roth IRA

Hi John, in order to invest via your Roth IRA, you will have to work directly with your IRA provider to facilitate your transaction. For more details, you can always reach out to support@wefunder.com.

Arrive AI(ARAI ON NASDAQ). Does anyone know the Stock Transfer Agent? I would like to transfer my shares to my brokerage account.

Hi Clinton, please reach out to support@wefunder.com for help with questions about transfer agents.

Now that the first funding Goal was met, will my investment still be evaluated at the $6.41/share price listed in the information details?

Hi Timothy, yes, all investments in our community round will get the $6.41/share price listed, regardless of what day you come into the round.

Hi, I do not find a maximum mentioned anywhere for this raise. Is it a round $1M or is there no ceiling at all?

Hi Josh, the maximum for this raise is $5M.

Hi! I'm fairly new to investing so I had a question about the initial funding round. Is what's being offered here that investors can contribute now, and then later purchase stock (at the rate of $6.41 per share), thus making two investments?

Hi Hannah! Not quite. What's being offered now to everyone and for the entire duration of the round is the purchase of preferred shares at $6.41 per share. So, only one investment, and everyone is getting the same terms whether you come in today or weeks from now. Everyone receives the same terms, regardless of when they join. Hope that helps clarify!

Siren Biotechnology

Turning deadly cancers into treatable diseases, backed by Founders Fund

sirenbiotechnology.com

San Francisco, CA

Technology Notable Angel Female Founder Healthcare Biotech

What Investors Say

LEAD INVESTOR

Invested $200,000 this round

Siren Biotechnology is bringing groundbreaking cancer therapies to patients in need. They are developing a brand new class of therapies that is set to transform the treatment landscape for some of the deadliest cancers. The Siren Biotechnology team is equipped with world-class gene therapy and oncology expertise, and their data to date shows immense promise in treating deadly brain cancers. Our investment is an expression of confidence in Siren Biotechnology's scientific innovation, their ability to navigate the complexities of the regulatory landscape, and their power to deliver on the massive potential of AAV immuno-gene therapy for patients.

What People Say

Siren Biotechnology

Quick facts

Team profiles

Featured investor profiles

What Investors Say